Stanford team + YC endorsement, Astraea's choice in this direction is too spot-on.

Astraea is an AI-native platform designed to automate the biostatistics processes of clinical trials. By inputting raw data, trial protocols, and metadata, it automatically generates SDTM, ADaM datasets, TFLs, and FDA-ready outputs that comply with CDISC standards. Traditional processes typically take 9 months and involve a team of 5-10 people, but this platform can complete the task within days. Currently focused on oncology and rare diseases, it is led by co-founders Joshua Wang (CEO) with a Stanford background and Sanmay Sarada (CTO), and has received support from YC.